Newfound Research LLC Baxter International Inc Transaction History

Newfound Research LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$63.83 - $80.0 $99,383 - $124,560	-1,557 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$76.85 - $89.45 $19,596 - $22,809	-255 Reduced 14.07%	1,557 $121,000
Q4 2021 Jan 19, 2022	BUY	$74.57 - $87.19 $28,784 - $33,655	386 Added 27.07%	1,812 $156,000
Q3 2021 Oct 14, 2021	BUY	$73.77 - $83.61 $28,991 - $32,858	393 Added 38.04%	1,426 $115,000
Q2 2021 Jul 19, 2021	BUY	$80.5 - $88.01 $4,427 - $4,840	55 Added 5.62%	1,033 $83,000
Q1 2021 Apr 28, 2021	SELL	$76.38 - $86.03 $35,134 - $39,573	-460 Reduced 31.99%	978 $82,000
Q4 2020 Jan 22, 2021	BUY	$75.39 - $82.36 $83,682 - $91,419	1,110 Added 338.41%	1,438 $115,000
Q3 2020 Oct 20, 2020	BUY	$78.33 - $90.73 $25,692 - $29,759	328 New	328 $26,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.3B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

Stay updated on Newfound Research LLC with notifications on news.